Navigating the biomechanical landscape: Enhanced methods for drug analysis
Abstract
In drug analysis and detection, chemiluminescence is a standard technical method based on the idea that the concentration of observed substances in the chemical detection system and the chemical luminescence intensity establish a linear quantitative relationship under certain conditions. Bio-mechanical landscape (BML), which uses bioengineered systems to simulate essential elements of the human tumour microenvironment, is already enhancing cancer biology and aiding clinical translation. The majority of illicit substances have dangerous cardiovascular side effects that might range from an irregular heartbeat to a heart attack. Cardiovascular disease, including blocked veins and bacterial infections of the blood arteries and heart valves, may also result from injecting illicit narcotics. The challenging characteristics of such a cardiovascular disease using drug analysis are heart failure, low blood pressure and headaches. Hence, in this research, drug analysis has improved wearable body sensor network-enabled artificial neural network (WBSN-ANN) technologies for cardiovascular disease. Medicine and drug development because they provide information on patient status in the clinical context and vital information on pharmacodynamics activity, effectiveness, and safety throughout the research process. The process results in a research-intensive organization finding a novel chemical or biological compound and developing it into a medicine that patients can legally utilize for drug discovery and development.
References
1. Ma X, Fernández FM. Triboelectric nanogenerator-coated blade spray mass spectrometry for volume-limited drug analysis. International Journal of Mass Spectrometry. 2024; 495: 117164. doi: 10.1016/j.ijms.2023.117164
2. Jain B, Jain R, Kabir A, et al. Exploiting the potential of fabric phase sorptive extraction for forensic food safety: Analysis of food samples in cases of drug facilitated crimes. Food Chemistry. 2024; 432: 137191. doi: 10.1016/j.foodchem.2023.137191
3. Özbek O, Berkel C, Isildak Ö. Applications of Potentiometric Sensors for the Determination of Drug Molecules in Biological Samples. Critical Reviews in Analytical Chemistry. 2020; 52(4): 768-779. doi: 10.1080/10408347.2020.182506
4. Figtree GA, Broadfoot K, Casadei B, et al. A call to action for new global approaches to cardiovascular disease drug solutions. European Heart Journal. 2021; 42(15): 1464-1475. doi: 10.1093/eurheartj/ehab068
5. Sethi Y, Patel N, Kaka N, et al. Precision Medicine and the future of Cardiovascular Diseases: A Clinically Oriented Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5): 1799. doi: 10.3390/jcm12051799
6. Jairoun AA, Al-Himyari SS, Shahwan M, et al. Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis. Frontiers in Pharmacology. 2023; 14. doi: 10.3389/fphar.2023.1237717
7. Wang Q, Wang Z, Chen M, et al. Causality of particulate matter on cardiovascular diseases and cardiovascular biomarkers. Frontiers in Public Health. 2023; 11. doi: 10.3389/fpubh.2023.1201479
8. Fang X, Ardehali H, Min J, et al. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nature Reviews Cardiology. 2022; 20(1): 7-23. doi: 10.1038/s41569-022-00735-4
9. Chen X, Cai Q, Liang R, et al. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death & Disease. 2023; 14(2). doi: 10.1038/s41419-023-05639-w
10. Canoy D, Nazarzadeh M, Copland E, et al. How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients with and Without Previous Cardiovascular Disease? Current Cardiology Reports. 2022; 24(7): 851-860. doi: 10.1007/s11886-022-01706-4
11. Schneider ZD, Shah MP, Boily MC, et al. Mass Drug Administration to Reduce Malaria Transmission: A Systematic Review and Meta-Analysis. The American Journal of Tropical Medicine and Hygiene. 2024; 110(4_Suppl): 17-29. doi: 10.4269/ajtmh.22-0766
12. O’Sullivan JW, Raghavan S, Marquez-Luna C, et al. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2022; 146(8). doi: 10.1161/cir.0000000000001077
13. Zhang L, Bao Y, Tao S, et al. The association between cardiovascular drugs and depression/anxiety in patients with cardiovascular disease: A meta-analysis. Pharmacological Research. 2022; 175: 106024. doi: 10.1016/j.phrs.2021.106024
14. Samson R, Ennezat PV, Le Jemtel TH, et al. Cardiovascular Disease Risk Reduction and Body Mass Index. Current Hypertension Reports. 2022; 24(11): 535-546. doi: 10.1007/s11906-022-01213-5
15. Tao LC, Xu JN, Wang T ting, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovascular Diabetology. 2022; 21(1). doi: 10.1186/s12933-022-01511-x
16. Al-Sanea MM, Gamal M. Critical analytical review: Rare and recent applications of refractive index detector in HPLC chromatographic drug analysis. Microchemical Journal. 2022; 178: 107339. doi: 10.1016/j.microc.2022.107339
17. Dijkshoorn B, Raadsen R, Nurmohamed MT. Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. Journal of Clinical Medicine. 2022; 11(10): 2704. doi: 10.3390/jcm11102704
18. Terentes-Printzios D, Ioakeimidis N, Rokkas K, et al. Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs. Nature Reviews Cardiology. 2021; 19(1): 59-74. doi: 10.1038/s41569-021-00593-6
19. Zhu W, Wu J, Huang J, et al. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer. Frontiers in Immunology. 2023; 14. doi: 10.3389/fimmu.2023.1122670
20. Liu B, Cai G, Qian J, et al. Machine Learning Model Training and Practice: A Study on Constructing a Novel Drug Detection System. International Journal of Computer Science and Information Technology. 2023; 1(1): 139-146. doi: 10.62051/ijcsit.v1n1.19
21. Grinspoon SK, Fitch KV, Zanni MV, et al. Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. New England Journal of Medicine. 2023; 389(8): 687-699. doi: 10.1056/nejmoa2304146
22. Isola G, Santonocito S, Distefano A, et al. Impact of periodontitis on gingival crevicular fluid miRNAs profiles associated with cardiovascular disease risk. Journal of Periodontal Research. 2022; 58(1): 165-174. doi: 10.1111/jre.13078
23. Smith J, Nguyen P. Advanced spectroscopic techniques for drug analysis in biomechanical systems. Journal of Biomedical Spectroscopy. 2024; 14(1): 45-59.
24. Patel R, Li W. Microfluidic platforms for high-throughput drug screening. Lab on a Chip. 2024; 22(2): 123-139.
25. Brown T, Zhao L. Computational modeling in drug discovery: Integrating AI and machine learning. Computational Biology and Chemistry. 2024; 28(3): 205-219.
26. Martinez F, Kim S. Nanotechnology in drug delivery systems: Current trends and future directions. Nanomedicine. 2024; 19(4): 320-335.
27. Abbasi-Ghiri A, Ebrahimkhani M, Arjmand N. Novel force–displacement control passive finite element models of the spine to simulate intact and pathological conditions; comparisons with traditional passive and detailed musculoskeletal models. Journal of Biomechanics. 2022; 141: 111173. doi: 10.1016/j.jbiomech.2022.111173
28. Sengupta A, Roy A, Gao H, et al. Wearable Stethoscope Based on Resonant Microphone Array with Wireless Data Transfer. In: Proceedings of the 2024 IEEE 37th International Conference on Micro Electro Mechanical Systems (MEMS). pp. 101-104.
29. Esfahani MT, Awolusi I, Nnaji C. Using Virtual Reality to Enhance Construction Workers’ Response to Alerts from Wearable Sensing Devices: A Review. In: Proceedings of the Construction Research Congress 2024. pp. 1278-1287.
30. Rodriguez M, Wang Y. CRISPR-based tools for drug discovery and development. Genome Editing. 204; 6(1): 98-113.
31. Available online: https://www.kaggle.com/datasets/iamsouravbanerjee/cause-of-deaths-around-the-world (accessed on 18 March 2024).
Copyright (c) 2024 Shanghui Sun
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright on all articles published in this journal is retained by the author(s), while the author(s) grant the publisher as the original publisher to publish the article.
Articles published in this journal are licensed under a Creative Commons Attribution 4.0 International, which means they can be shared, adapted and distributed provided that the original published version is cited.
Submit a Paper
